Many Women Being Diagnosed with Thyroid Nodules? — What the Science Says
Reading time: 10'

Many Women Being Diagnosed with Thyroid Nodules? — What the Science Says

Louise W Lu

Written by

Louise W Lu, PhD, MPH, BMLS

Alexandra V Goldberg

Written/Reviewed by

Alexandra V Goldberg, Registered Dietitian


“You have a thyroid nodule. Please follow up regularly.” — That’s often how many women first hear about their thyroid issue. No symptoms, no pain, but the word alone triggers unease. Is it cancer? Will it grow? Should I be taking supplements?

This experience is increasingly common.
According to GLOBOCAN 2022 published by the International Agency for Research on Cancer (IARC) under the World Health Organization (WHO), thyroid cancer ranks as the 7th most common cancer among women worldwide, with a female incidence rate nearly three times higher than that of men. In countries with widespread ultrasound screening, the detection of thyroid abnormalities has surged — making it feel like a new “modern epidemic.”

What’s more concerning is this: Over half — and in some countries, up to 90% of these diagnosed cases may be overdiagnoses.

A study published in JAMA Internal Medicine revealed that although women are diagnosed with thyroid cancer far more frequently than men, postmortem studies show no significant gender difference in the true prevalence of subclinical thyroid cancer. In other words, many of these "cancers" might never cause symptoms or affect lifespan — they’re simply caught earlier because of how sensitive our scans have become.

That doesn’t mean we should ignore thyroid nodules. But it does remind us to think critically: Which nodules truly require attention? Why are women more likely to develop them? What silent mechanisms in the body are driving them to grow?

In this blog series, I’ll help you unpack the biology behind thyroid nodules step by step — from hormones, stress, and diet to nutritional strategies — so you can take back control. And we begin with the most overlooked but foundational question: Why are thyroid nodules so common in women?

 


 

 

 


 

Why Are Women More Likely to Develop Thyroid Nodules?

In health check reports, thyroid nodules are commonly found in women aged 35 to 55. Interestingly, men rarely face this issue — and even when they do, the nodules are usually small and stable. So why does this “silent lump” show up more frequently in women?

It comes down to three overlapping physiological mechanisms:

① Women’s thyroids are highly sensitive to estrogen
The epithelial cells of the thyroid contain a high density of estrogen receptors, especially the ER-α type. When estrogen levels fluctuate (during puberty, pregnancy planning, or perimenopause) or when liver detox pathways are sluggish, prolonged high levels of estrogen can continuously stimulate the thyroid, triggering cell proliferation and structural changes that lead to nodules.

Even if your lab results show “normal” estrogen, if your metabolic clearance is slow (due to constipation, lack of sleep, or low fat intake), your body may still be in a state of estrogen overload.

② The female stress axis (HPA axis) more readily disrupts thyroid hormone balance
Chronic stress can overstimulate the hypothalamic–pituitary–adrenal (HPA) axis, suppressing stable secretion of TSH (thyroid-stimulating hormone). To compensate, the body may enlarge the thyroid structurally to maintain metabolic function — and nodules begin to form.

If you’re often anxious at night, fatigued during the day, or tend to feel cold, your body might be dealing with chronic stress and overworked thyroid function.

③ Long-term exposure to endocrine-disrupting chemicals (EDCs)
Women are far more likely than men to use skincare products, sunscreens, or drink from plastic bottles. These products often contain hormone-disrupting compounds (like phthalates or BPA), which mimic estrogen and act on thyroid receptors, increasing cellular stimulation and nodule growth.

Numerous studies suggest that the heavier the exposure to EDCs, the higher the detection rate of thyroid nodules — especially in younger women.

In short, women are not more prone to thyroid nodules because they are “weaker,” but because their endocrine systems are more complex, their thyroids more sensitive to internal and external shifts, and their bodies more vulnerable to emotional and detox-related stress.

Next, we’ll turn to an often-overlooked yet critical organ: the liver.
It’s not only in charge of clearing out estrogen — it also controls how usable your thyroid hormones really are.

 


 

Liver Overload: The Hidden Trigger Behind Nodule Growth

When women first hear they have thyroid nodules, many instinctively ask, “Am I not getting enough iodine?”

But in reality, nodules often form not because of missing nutrients — but because the body's detox systems, especially the liver, are silently overworked.

The liver is your body’s cleanup crew. It metabolizes not only alcohol and medication, but also excess estrogen, aged hormones, and free radical byproducts — converting them into water-soluble forms for elimination through bile or urine.

When you're frequently constipated, sleep-deprived, undernourished, lacking antioxidants, or taking multiple medications, your liver detox capacity drops.

As a result, hormones that should have been eliminated get recirculated — and in hormone-sensitive organs like the thyroid, this leads to chronic stimulation, cellular overgrowth, and accelerated nodule formation.

What’s more, the liver plays a key role in “activating” thyroid hormones:

  • The thyroid primarily produces T4 — a precursor form. It must be converted in the liver (and partly kidneys) into T3, the active hormone;
  • If your liver is underperforming, T4 may not effectively convert to T3;
  • Even if your thyroid lab results look “normal,” you might still feel cold, fatigued, or metabolically slow.

In other words—
You may think it’s a thyroid issue, but the root cause could be an overworked liver.

In the next section, we’ll break down the common “TR classification” you see on ultrasound reports — so you can understand your personal risk level and whether intervention is needed.

 


 

Understanding the TR Classification: Does Your Nodule Need Attention?

“Your nodule isn’t big — we’ll just monitor it.”
“This looks like a TR4. I suggest regular follow-up and possibly a biopsy.”
— You may have heard similar remarks during a check-up, but what exactly is the TR score? And how does it help you decide whether to act?

What is the TR classification?
TR stands for TI-RADS — the Thyroid Imaging Reporting and Data System. It’s a standardized scoring system used by radiologists to assess the malignancy risk of thyroid nodules based on ultrasound features. TR1 to TR5 ranks nodules from benign to highly suspicious. The higher the number, the closer the imaging features are to potential malignancy.

Mobile users: scroll sideways to view full table

TR Grade Description Estimated Cancer Risk Recommended Action
TR1 Normal structure ~0% No action needed
TR2 Clearly benign <2% No action, routine checkups
TR3 Low suspicion 2–5% Annual follow-up
TR4 Intermediate suspicion 5–10% Close monitoring, possible biopsy
TR5 High suspicion ≥20% Biopsy or further diagnostic evaluation

For most women, nodules are categorized as TR2 to TR4 — meaning low to intermediate risk.

TR3 and TR4 are not “pre-cancer,” but they are a turning point.
These nodules aren't clearly benign (like cysts or calcified nodules), but they also don’t show clear malignant signs. They may have blurred margins, irregular shapes, or slight blood flow on imaging.

At this stage, many women feel torn:

  • It's not cancer, but doctors still recommend annual scans or even biopsy — the anxiety builds.
  • Doing nothing risks further nodule growth.
  • It’s unclear whether to take medication, supplement iodine, or avoid certain foods.

But this is exactly when nutrition has the greatest potential to intervene and help stabilize your nodules.

In clinical nutrition practice, many TR3–TR4 nodules remain stable — or even slowly shrink — over years when clients begin supporting estrogen clearance, liver function, and stress resilience.

In the next section, we’ll wrap up this article and guide you to a short questionnaire to help identify whether your nodule is more likely stress-related, hormone-driven, or metabolism-linked. That will shape your personal roadmap for nutritional care in this series.

 


 

Final Thoughts|You Don’t Have to Wait for Your Nodule to Grow Before Taking Action

The rising rate of thyroid nodules isn’t a sign that women’s health is deteriorating — it reflects the world we live in: one shaped by hormonal disruptors, chronic stress, and metabolic overload. Women, with their more sensitive endocrine systems, are often the first to show signs.

Here’s what you’ve learned:

  • Why women are more prone to nodules — estrogen sensitivity, stress response, and environmental exposures all play a role;
  • Nodules aren’t just a thyroid issue — your liver is the deeper metabolic switchboard;
  • TR grading helps assess risk — and TR3–TR4 is the sweet spot where nutrition can make a meaningful difference.

But knowledge alone isn’t enough.
The next question is: What kind of nodule do you have — and what kind of support does your body need?

🎯 Take the Quiz: Find Out What Nutritional Strategy Fits Your Nodule Type

👉 Click to Begin: Your Thyroid Nodule Type Quiz (2 mins)

This short quiz will help you identify whether your body shows signs of:

  • Stress-driven nodules: Often seen in anxiety, poor sleep, daytime fatigue, HPA axis imbalance;
  • Metabolic-type nodules: Common in those with sluggish liver function, constipation, poor detox, weight gain;
  • Hormonal-type nodules: Often associated with poor estrogen clearance, PCOS, or fibrocystic conditions.

In upcoming posts, I’ll share personalized nutrition plans for each of these types — from food choices to supplements, sleep routines to stress strategies — so you can build a rhythm that truly fits your body.

 

Authors:

Louise W Lu

Louise W Lu

Registered Nutritionist (NZ Reg. 82021301), PhD of Nutrition Science, Honorary Academic at the University of Auckland. Louise blends clinical research with public health to help people eat better and live stronger.

All Posts  •  Website

Alexandra V Goldberg

Alexandra V Goldberg

Registered Dietitian (NZ Reg. 20-02273) and expert in nutrition, medicinal chemistry, and skincare. Alexandra helps clients reach their health goals with science-backed strategies in post-op recovery, feeding tolerance, and weight management.

All Posts  •  Website

2 comments

Shirley
Shirley

想了解一下甲状腺结节诊断的原理和过程,谢谢🙏

Shirley
Shirley

想了解一下甲状腺结节诊断的原理和过程,谢谢🙏

Leave a comment